Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › TX › San Angelo › NPI 1992707228
Clinic

Shannon Medical Center

Shannon Medical Center was paid $9.99M by Medicaid between Nov 2020 and Dec 2024, across 197 billing codes. Its largest line is 99284, emergency room visit (serious) — 47% of everything it billed.

33Billing provider infoSHANNON MEDICAL CENTER
SAN ANGELO, TX 76903
33aNPI1992707228assigned 05/31/2005
33bProvider typeAmbulatory Surgical Clinic/Center
28Total paid$9.99M
24GClaims321,706
24DCodes billed197
24AFirst – last monthNov 2020 – Dec 2024
Compared with peers

Next to other Ambulatory Surgical Clinic/Center providers in Texas

Rank by total paid#46 of 320
Median peer was paid$205K
This provider vs. median49×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2020667$59K
202184,481$2.14M
2022104,287$3.52M
202382,550$3.26M
2024incomplete49,721$1.01M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 47% 15,751 14,775 $4.71M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 9.3% 19,324 18,675 $928K
41899 Unlisted procedure, dentoalveolar structures 5.5% 373 339 $546K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 3.6% 3,122 2,902 $364K
42820 Tonsillectomy and adenoidectomy; younger than age 12 3.4% 92 89 $337K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 2.8% 4,867 4,658 $285K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 2.8% 4,871 4,662 $285K
80053 Comprehensive metabolic panel 2.3% 29,305 25,868 $234K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 2.1% 31,605 27,414 $211K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 1.4% 2,677 2,568 $144K
0202U Oncology (prostate), multianalyte, gene expression profiling 1.4% 2,793 2,726 $139K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 1.2% 2,674 2,603 $115K
185 more codes
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 1.1% 172 $109K
87800 1.1% 1,632 $108K
84443 Thyroid stimulating hormone (TSH) <1% 9,543 $89K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 1,191 $81K
74177 Computed tomography, abdomen and pelvis; with contrast material <1% 1,238 $66K
86780 <1% 2,800 $66K
86850 <1% 2,276 $55K
99213 Doctor's office visit, returning patient (routine) <1% 537 $54K
87086 Culture, bacterial; quantitative colony count, urine <1% 6,762 $44K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 2,336 $43K
71045 Radiologic examination, chest; single view <1% 3,266 $40K
81001 <1% 14,710 $39K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 561 $37K
80061 Lipid panel <1% 8,772 $36K
70450 Computed tomography, head or brain; without contrast material <1% 1,736 $34K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 4,822 $32K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 3,105 $31K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 837 $30K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 416 $29K
84481 <1% 2,035 $27K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 4,676 $27K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 2,021 $25K
83655 <1% 872 $25K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 1,124 $23K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 2,489 $22K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 467 $22K
88142 <1% 1,273 $21K
84439 <1% 3,642 $19K
87070 <1% 2,200 $18K
71046 Radiologic examination, chest; 2 views <1% 630 $17K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 397 $16K
96361 Intravenous infusion, hydration; each additional hour <1% 1,139 $16K
84702 <1% 987 $16K
36415 Collection of venous blood by venipuncture <1% 16,048 $15K
77067 Screening mammography, bilateral, including computer-aided detection <1% 1,362 $15K
84703 <1% 2,360 $15K
83036 Hemoglobin; glycosylated (A1C) <1% 5,522 $13K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 555 $13K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 269 $12K
86003 <1% 68 $12K
69436 Tympanostomy (requiring insertion of ventilating tube), general anesthesia <1% 13 $12K
77063 Screening digital breast tomosynthesis, bilateral <1% 1,362 $12K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 1,773 $12K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 490 $11K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 92 $11K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 356 $10K
87486 <1% 169 $9K
87581 <1% 170 $9K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 2,009 $9K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 211 $8K
87150 <1% 104 $8K
83880 <1% 3,270 $7K
82728 <1% 1,514 $7K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 747 $7K
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 130 $6K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 1,025 $6K
83690 <1% 2,817 $5K
84484 <1% 3,159 $5K
81025 <1% 822 $5K
85027 <1% 2,792 $5K
83970 <1% 1,276 $5K
87340 <1% 433 $4K
86803 <1% 600 $4K
82043 <1% 2,142 $4K
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 893 $4K
J0134 Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg <1% 455 $4K
86762 <1% 143 $3K
72125 Computed tomography, cervical spine; without contrast material <1% 264 $3K
71250 <1% 104 $3K
71275 Computed tomographic angiography, chest, with contrast material <1% 63 $3K
83735 <1% 3,639 $3K
80048 Basic metabolic panel (calcium, ionized) <1% 2,844 $3K
84144 <1% 51 $3K
85379 <1% 1,306 $3K
86901 <1% 1,093 $3K
86900 <1% 1,096 $3K
87186 <1% 2,624 $3K
96375 Therapeutic injection; each additional sequential IV push <1% 1,997 $2K
82105 <1% 160 $2K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 457 $2K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 65 $2K
84145 <1% 239 $2K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring <1% 84 $2K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 45 $2K
85018 <1% 358 $2K
82947 <1% 209 $2K
85610 <1% 2,253 $2K
87507 <1% 18 $2K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 41 $2K
29581 <1% 237 $2K
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 79 $2K
83605 <1% 1,056 $2K
77080 <1% 346 $1K
82077 <1% 462 $1K
86140 <1% 1,190 $1K
82607 <1% 958 $1K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 58 $1K
83550 <1% 1,387 $1K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 1,731 $1K
84146 <1% 337 $1K
80164 <1% 503 $1K
76830 Ultrasound, transvaginal <1% 12 $1K
85007 <1% 820 $1K
87040 <1% 372 $1K
66984 Extracapsular cataract removal with insertion of intraocular lens prosthesis <1% 25 $1K
83540 <1% 1,540 $999.86
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 12 $993.33
87077 <1% 1,513 $991.98
80069 <1% 1,674 $985.75
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 91 $911.23
96367 <1% 154 $902.76
93971 <1% 55 $869.52
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser <1% 57 $787.76
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 2,681 $776.84
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 1,590 $746.07
76801 <1% 13 $686.76
86592 <1% 71 $677.05
93017 <1% 80 $668.31
82140 <1% 190 $663.58
83615 <1% 273 $648.05
82570 <1% 1,861 $642.63
82550 <1% 474 $628.94
86787 <1% 13 $438.08
72131 <1% 25 $394.11
82746 <1% 222 $391.82
J7050 Infusion, normal saline solution, 250 cc <1% 105 $383.13
85014 <1% 65 $342.89
85652 <1% 775 $314.25
82040 <1% 597 $312.97
87205 <1% 252 $304.87
85730 <1% 180 $301.28
84156 <1% 1,017 $278.52
88342 <1% 74 $278.04
70486 <1% 13 $270.85
82150 <1% 220 $236.53
J2270 Injection, morphine sulfate, up to 10 mg <1% 573 $231.91
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 28 $230.23
82565 <1% 583 $227.58
82805 <1% 27 $215.82
80299 <1% 27 $172.26
J7120 Ringers lactate infusion, up to 1000 cc <1% 439 $171.06
84550 <1% 687 $168.25
84153 <1% 303 $166.73
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 66 $129.78
80179 <1% 29 $129.34
80143 <1% 30 $129.34
J0690 Injection, cefazolin sodium, 500 mg <1% 230 $128.78
82274 <1% 104 $118.24
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 779 $117.40
J2785 Injection, regadenoson, 0.1 mg <1% 38 $111.69
J3010 Injection, fentanyl citrate, 0.1 mg <1% 1,018 $99.14
84100 <1% 374 $85.37
J1644 Injection, heparin sodium, per 1000 units <1% 335 $84.91
A6258 Transparent film, sterile, more than 16 sq. in. but less than or equal to 48 sq. in., each dressing <1% 70 $57.98
84403 <1% 25 $57.04
82962 <1% 2,809 $47.09
J1170 Injection, hydromorphone, up to 4 mg <1% 74 $34.25
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 749 $32.44
84436 <1% 45 $31.45
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg <1% 84 $30.19
C1769 Guide wire <1% 112 $26.38
80354 <1% 12 $25.62
83001 <1% 12 $25.45
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 12 $22.56
J1790 Injection, droperidol, up to 5 mg <1% 32 $21.26
J0689 Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg <1% 30 $18.14
80178 <1% 14 $16.65
80050 General health panel <1% 13 $12.15
J7030 Infusion, normal saline solution , 1000 cc <1% 15 $11.46
83883 <1% 26 $11.42
80197 <1% 21 $10.95
82248 <1% 111 $7.85
J1650 Injection, enoxaparin sodium, 10 mg <1% 13 $7.28
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 13 $3.22
J2060 Injection, lorazepam, 2 mg <1% 14 $1.61
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units 0% 270 $0.00
80177 0% 13 $0.00
G0378 Hospital observation service, per hour 0% 39 $0.00
G0103 Prostate cancer screening; prostate specific antigen test (psa) 0% 13 $0.00
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 0% 14 $0.00
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 0% 3,501 $0.00
A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose 0% 85 $0.00
C1780 Lens, intraocular (new technology) 0% 26 $0.00
84425 0% 12 $0.00
99152 0% 18 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialKIRKHAM, PATRICIA (BILLING SUPERVISOR)